Preliminary data shows German firm's COVID-19 vaccine produces antibodies, immune cells, says European Medicines Agency

The rolling review will continue until enough evidence is available for a formal marketing authorization application

European regulator begins review of CureVac jab

The vaccine is administered via two injections into the arm, the second between 4 and 12 weeks after the first

A health worker fills a syringe with a dose of the Oxford/AstraZeneca COVID-19 vaccine at the Appleton Village Pharmacy, amid the coronavirus disease (COVID-19) outbreak, in Widnes, Britain, January 14, 2021.

European regulator begins review of CureVac jab

European regulator gives green light for Astra-Oxford COVID-19 vaccine

# european medicines agency en

European regulator begins review of CureVac jab

European regulator gives green light for Astra-Oxford COVID-19 vaccine